Porton Biologics

BiotechnologySeries BSuzhou, Chinaportonbio.com

Latest round

Series B

Last raised

Aug 2022

Total raised

$138M

Investors

12

About Porton Biologics

Established in 2018 and based in Suzhou, China, Porton Biologics Ltd. is a contract development and manufacturing organization(CDMO)., which is listed on the Shenzhen Stock Exchange. The company is located in Suzhou Industrial Park, with a building area of about 5000 square meters. It has GMP process scale-up and pilot production workshops and CAR-T cell amplification laboratories designed and built according to cGMP, FDA, EU-GMP and NMPA standards. The company provides gene and cell therapy CDMO services and has built a CDMO platform that integrates plasmids, cell therapy, gene therapy, lytic virus, nucleic acid therapy and live bacteriophage therapy, and is able to provide customers with services to analyze and test data. These include protein quantification, physicochemical analysis, etc.

Who invested in Porton Biologics

12 investors across 2 rounds

See all investors in Porton Biologics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Aug 19, 2022

    Amount

    $76M

    Investors

    Locked

  2. Series A

    Apr 16, 2021

    Amount

    $62M

    Investors

    Locked

Questions about Porton Biologics

Who invested in Porton Biologics?

Porton Biologics has 12 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Porton Biologics raised?

Porton Biologics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Porton Biologics last raise money?

Porton Biologics's most recent round on record is a Series B, in Aug 2022.

What does Porton Biologics do?

Established in 2018 and based in Suzhou, China, Porton Biologics Ltd.

Where is Porton Biologics headquartered?

Porton Biologics is headquartered in Suzhou, China.

Which VCs invest in companies like Porton Biologics?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Porton Biologics's stage. Their profiles are linked below.

Raising like Porton Biologics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.